Dr. Kade
DR. KADE is a privately-held, family-owned German pharmaceutical company founded in 1886, manufacturing and distributing OTC medicines and dermocosmetics for women's health, proctology, heartburn, children's vitamins, and sensitive skincare through German pharmacies and licensing partnerships.
- Company typePrivate
- Founded1886
- HeadquartersBerlin, Germany
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Dr. Kade does
DR. KADE Pharmazeutische Fabrik GmbH is a privately-held, family-owned German pharmaceutical company founded in 1886 in Berlin. The company develops, manufactures, and distributes over-the-counter (OTC) pharmaceutical products and dermocosmetics, organized around six health fields: women's health (gynecology), proctology, gastroenterology/heartburn, children's vitamins, tonics, and dermocosmetics. Its portfolio includes established German brands such as KadeFungin (antifungal vaginal treatment), KadeFlora (probiotic vaginal capsules), KadeZyklus (menstrual health remedies), Faktu lind (hemorrhoid treatment), RIOPAN (antacid), Multi-Sanostol (children's multivitamin syrup), and Buer Lecithin (energy tonic sold since 1934 and Germany's best-known Lecithin brand). DR. KADE also operates the SIRIDERMA dermocosmetics line through its wholly-owned subsidiary SIRIUS, offering alkaline skincare for sensitive skin conditions such as atopic dermatitis and psoriasis.
Manufacturing is conducted at the company's GMP-certified Berlin-Marienfelde facility, which serves as a competence center for semi-solid pharmaceutical dosage forms including creams, ointments, and suppositories. The company additionally offers licensing and contract manufacturing (Lohnherstellung) services to domestic and international partners, extending its production capacity utilization beyond its own branded portfolio.
The business model combines B2C OTC sales through German pharmacies with B2B licensing and contract manufacturing revenue. Distribution is executed via a field sales force organized regionally (Region Ost, Region Süd) targeting pharmacy customers, supplemented by professional HCP engagement platforms including the aKADEmie pharmacy portal and DocCheck eCME training. Pricing follows the German Drug Price Regulation (Arzneimittelpreisverordnung), and the company employs 300+ people across two Berlin locations. In March 2020, DR. KADE acquired Daizu GmbH, expanding its corporate footprint.
Dr. Kade firmographics
Firmographics- Name
- Dr. Kade
- Legal name
- DR. KADE Pharmazeutische Fabrik GmbH
- Website
- https://kade.de
- Company type
- Private
- Founded year
- 1886
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- DR. KADE is a privately-held, family-owned German pharmaceutical company founded in 1886, manufacturing and distributing OTC medicines and dermocosmetics for women's health, proctology, heartburn, children's vitamins, and sensitive skincare through German pharmacies and licensing partnerships.
- Ownership category
- akta.pro rank
Dr. Kade industry classification
Industry- Product category
- OTC Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Women’s Health (OTC Gynecologic) (HLAIADAJ)
- akta.pro secondary industries
- Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF), Sleep, Stress & Mood Support (HLAIADAG), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)
Keywords
Where Dr. Kade is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices3 records
Markets served
Dr. Kade business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- OTC Pharmaceutical Products: Over-the-counter pharmaceutical products sold through pharmacies including women's health products (KadeFungin, KadeFlora, KadeZyklus), proctology products (Faktu lind), heartburn treatments (RIOPAN), children's vitamins (Multi-Sanostol), and tonics (Buer Lecithin). Products are prescription-free medications available in pharmacies.
- Licensing & Contract Manufacturing: The company offers licensing partnerships and contract manufacturing (Lohnherstellung) services for pharmaceutical products. They produce products for partners in domestic and international markets.
- Dermocosmetics (SIRIDERMA): Specialized alkaline dermocosmetics sold through pharmacies and directly via siriderma.de, developed and manufactured in Germany by subsidiary SIRIUS.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Wholesale pricing for pharmacies |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels8 records
Dr. Kade product offering
Product offeringCore offering
DR. KADE manufactures and distributes over-the-counter (OTC) pharmaceutical products across women's health, proctology, gastroenterology, children's vitamins, tonics, and dermocosmetics through German pharmacies and licensing/contract manufacturing partnerships. The company operates GMP-certified production in Berlin specializing in semi-solid dosage forms (creams, ointments, suppositories), with well-established brands including KadeFungin, RIOPAN, Multi-Sanostol, and Buer Lecithin, alongside the SIRIDERMA dermocosmetics line via subsidiary SIRIUS.
Product overview
Dr. KADE is a mid-sized German pharmaceutical company founded in 1886, specializing in OTC medicines and healthcare products for conditions that are difficult to discuss openly. The company operates across six health fields: women's health (gynecology), proctology, gastroenterology/heartburn, children's vitamins, tonics, and dermocosmetics. The product portfolio includes branded OTC pharmaceuticals such as KadeFungin® 3 (antifungal vaginal treatment), KadeFlora® (probiotic vaginal capsules), KadeZyklus® (menstrual health remedies), Faktu® lind (hemorrhoid treatment), RIOPAN® (antacid), Multi-Sanostol® (multivitamins), and Buer® Lecithin Plus Vitamins (energy tonic). The company also offers dermocosmetics through its SIRIDERMA sub-brand (alkaline skincare) via subsidiary SIRIUS. Products are manufactured in Germany, primarily at the Berlin-Marienfelde production site, with semi-solid forms (creams and ointments) representing a core manufacturing competency.
Differentiator
Problem solved
Functional benefit
Brands
- KadeFungin: Women's health products for vaginal fungal infections (Candida albicans)
- KadeFlora
- KadeZyklus
- Faktu lind
- RIOPAN
- Multi-Sanostol
- Buer Lecithin
- SIRIDERMA
- aKADEmie
Products and services
- KadeFungin 3 Antifungal vaginal medication available as cream, tablets, and combined package containing Clotrimazole for treating vaginal inflammation and discharge caused by Candida albicans yeast infections. Sold through pharmacies without prescription for women with vaginal fungal infections.
- KadeFlora Lactic acid bacteria vaginal capsules containing Lactiplantibacillus plantarum (strain P 17630) for normalizing disturbed vaginal flora after antibiotic treatment and maintaining normal flora in recurring infections.
- KadeZyklus (for heavy bleeding) Traditional plant-based medicine containing shepherd's purse dry extract (400mg film-coated tablets) for reducing heavy menstrual bleeding in women with regular cycles.
- KadeZyklus (for cramps) Traditional herbal medicine containing yarrow dry extract (250mg film-coated tablets) for symptomatic treatment of mild menstrual cramps.
- Faktu lind Hemorrhoid treatment available as ointment and suppositories containing witch hazel distillate and extract for relieving itching, oozing, and burning in early-stage hemorrhoids.
- RIOPAN Antacid medication containing Magaldrate available as stomach gel (1600mg) and chewable tablets (800mg, including mint flavor) for treating heartburn and acid-related stomach complaints.
- Multi-Sanostol Multivitamin syrup preparation for preventing combined vitamin deficiency states, available in standard and sugar-free formulations for children.
- Buer Lecithin Plus Vitamins Traditional plant-based tonic containing Lecithin from soybeans combined with B vitamins for improving well-being during fatigue and exhaustion and strengthening the nerves. Sold in pharmacies since 1934.
- SIRIDERMA Special alkaline skincare brand by subsidiary SIRIUS offering vegan, fragrance-free dermocosmetics based on natural ingredients for sensitive skin conditions such as atopic dermatitis, psoriasis, and very dry skin. Developed and manufactured in Germany.
- Licensing & Contract Manufacturing (Lohnherstellung) Licensing partnerships and contract manufacturing services for pharmaceutical products, producing products for partners in domestic and international markets.
Quantifiable outcome
- Buer Lecithin is the best-known and most successful Lecithin brand in Germany
Companies that use Dr. Kade
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles2 records
Dr. Kade technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Dr. Kade partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- SIRIUS (Subsidiary)coreSIRIUS is a subsidiary of DR. KADE that develops and manufactures the SIRIDERMA dermocosmetics brand. SIRIDERMA products are special alkaline skin care based on natural ingredients with vegan formulations.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Dr. Kade competitors and assessment
Company assessmentDirect peers
- Engelhard Arzneimittel GmbH & Co. KG: German mid-sized OTC pharmaceutical manufacturer based in Niederdorfelden, with a comparable portfolio of branded OTC products (proctology, dermatology, cough/cold) and a similar family-owned structure. Directly comparable on size, channel (pharmacy), and portfolio focus on sensitive or specialty OTC categories.
- Dermapharm Holding SE: German mid-sized pharmaceutical company focused on branded OTC, dermatology, and generics, listed in the SDAX. Highly comparable as a parallel OTC-and-dermocosmetic manufacturer with pharmacy-channel distribution and active M&A history (e.g., the Allergopharma acquisition).
- Klosterfrau Melisana GmbH: Cologne-based German OTC pharmaceutical company (part of the MCM Klosterfrau group) specializing in traditional herbal and natural OTC remedies (e.g., Klosterfrau Melissengeist, taxofit). Comparable on heritage (long-established brand portfolio), pharmacy channel, and botanical/herbal positioning similar to KadeZyklus and Buer Lecithin.
- Wörwag Pharma GmbH & Co. KG: Stuttgart-based, family-owned German pharmaceutical company focused on prescription medicines, OTC supplements, and dermatology products distributed through pharmacies. Comparable on family-owned structure, German mid-size scale, and pharmacy-led GTM.
- Cesra Arzneimittel GmbH & Co. KG: German mid-sized OTC manufacturer (part of the Redecker group) focused on herbal medicinal products for women's health, venous conditions, and immune support. Highly comparable on therapeutic-category focus (women's health, herbal OTC) and pharmacy distribution.
Broad incumbents
- STADA Arzneimittel AG: One of Germany's largest generic and OTC pharmaceutical manufacturers, with a broad pharmacy-channel portfolio including women's health, dermatology, and consumer health brands (e.g., Grippostad, Ladival). A larger incumbent in the same OTC categories where DR. KADE competes.
- Bayer Consumer Health (Bayer Vital GmbH): German arm of Bayer's global Consumer Health division, with major OTC brands in women's health, gastrointestinal, dermatology, and multivitamins (e.g., Canesten, Aspirin, Bepanthen). Comparable as a broad incumbent in many of the same OTC therapeutic categories where DR. KADE's brands compete for pharmacy shelf space.
- Ratiopharm (Teva Deutschland): Germany's largest OTC and generic pharmaceutical brand portfolio, owned by Teva. Directly comparable across multiple OTC categories (heartburn, women's health, vitamins), competing for the same pharmacy shelf and pharmacist recommendation as DR. KADE's brands.
- Perrigo Deutschland: European OTC and self-care products division of Perrigo, with a broad portfolio in women's health, dermatology, and consumer health. Comparable as a larger European OTC incumbent operating across several of the same therapeutic categories as DR. KADE.
Emerging players
- Biologische Heilmittel Heel GmbH: Baden-Baden-based pharmaceutical company specializing in natural, herbal-based medicines and dermocosmetics, with strong presence in women's health and gastroenterology categories. Comparable in therapeutic-category overlap (gynecology, gastroenterology) and natural/botanical positioning parallel to KadeZyklus and Buer Lecithin.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Dr. Kade social profiles
Digital presenceDr. Kade financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dr. Kade leadership team
Management profileNumber of profiles
Profiles5 records
Dr. Kade subsidiaries and ownership
Company hierarchySubsidiaries1 record
Dr. Kade funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dr. Kade M&A and investment
M&A and investmentM&A1 record
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dr. Kade
What does Dr. Kade do?
DR. KADE manufactures and distributes over-the-counter (OTC) pharmaceutical products across women's health, proctology, gastroenterology, children's vitamins, tonics, and dermocosmetics through German pharmacies and licensing/contract manufacturing partnerships. The company operates GMP-certified production in Berlin specializing in semi-solid dosage forms (creams, ointments, suppositories), with well-established brands including KadeFungin, RIOPAN, Multi-Sanostol, and Buer Lecithin, alongside the SIRIDERMA dermocosmetics line via subsidiary SIRIUS.
Is Dr. Kade a public or private company?
Dr. Kade is a private company. It is classified as family owned and is currently operating.
When was Dr. Kade founded?
Dr. Kade was founded in 1886. It employs 1 to 10 people.
Where is Dr. Kade based?
Dr. Kade is headquartered in Berlin, Germany, in the Europe region.
How does Dr. Kade make money?
Three revenue lines are on record. OTC Pharmaceutical Products are the primary driver. The others are licensing & Contract Manufacturing and dermocosmetics (SIRIDERMA).
Who are Dr. Kade's main competitors?
Direct peers on record are Engelhard Arzneimittel GmbH & Co. KG, Dermapharm Holding SE, Klosterfrau Melisana GmbH, Wörwag Pharma GmbH & Co. KG and Cesra Arzneimittel GmbH & Co. KG. Broad incumbents are STADA Arzneimittel AG, Bayer Consumer Health (Bayer Vital GmbH), Ratiopharm (Teva Deutschland) and Perrigo Deutschland. Biologische Heilmittel Heel GmbH is listed as an emerging player.
Does Dr. Kade have an API?
No public API is recorded for Dr. Kade.
What industry is Dr. Kade in?
Dr. Kade's product category is OTC Pharmaceuticals. Its primary akta.pro industry code is HLAIADAJ, Women’s Health (OTC Gynecologic), with a secondary code of CRADAMAF, Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal). Its NAICS code is 325412 and its SIC code is 2834.